切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2026, Vol. 15 ›› Issue (01) : 28 -32. doi: 10.3877/cma.j.issn.2095-3259.2026.01.007

妊娠合并子宫肌瘤

妊娠合并子宫腺肌症的妊娠结局
付以琳, 丁文成()   
  1. 430030 武汉,华中科技大学同济医学院附属同济医院产科 国家妇产疾病临床医学研究中心
  • 收稿日期:2025-10-23 出版日期:2026-02-18
  • 通信作者: 丁文成
  • 基金资助:
    国家重点研发计划《优化严重产后出血诊治策略的研究》(2021YFC2701500)

Pregnancy outcomes in women with adenomyosis

Yilin Fu, Wencheng Ding()   

  • Received:2025-10-23 Published:2026-02-18
  • Corresponding author: Wencheng Ding
引用本文:

付以琳, 丁文成. 妊娠合并子宫腺肌症的妊娠结局[J/OL]. 中华产科急救电子杂志, 2026, 15(01): 28-32.

Yilin Fu, Wencheng Ding. Pregnancy outcomes in women with adenomyosis[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2026, 15(01): 28-32.

子宫腺肌症是子宫内膜腺体和间质侵入子宫肌层的良性病变,其通过破坏子宫内膜-肌层交界区完整性,诱发慢性炎症和纤维化改变,对胚胎着床、胎盘形成及子宫收缩功能产生多维度影响,不仅影响生育能力,还显著增加妊娠全周期不良影响和结局的风险。妊娠早期,腺肌症可降低子宫内膜容受性并扰乱免疫微环境,增加流产风险。妊娠中晚期,因子宫结构异常和炎症介质释放,早产、胎盘位置异常及妊娠期高血压疾病发生率明显升高,尤以弥漫性腺肌症更为突出。分娩及产后阶段,子宫肌层收缩功能受损和胎盘并发症进一步增加产后出血和胎儿不良结局风险。本文系统梳理子宫腺肌症与多种不良结局的关联及可能的病理生理机制,强调应将其视为妊娠高危因素,建立分级风险评估体系,实施全孕期动态监测与个体化管理,以改善母婴结局。

Adenomyosis is a benign condition characterized by the presence of endometrial glands and stroma with the myometrium.It not only impairs fertility but also significantly increases the risk of adverse pregnancy outcomes. By disrupting the integrity of the endometrial-myometrial junction and inducing chronic inflammation and fibrotic remodeling, adenomyosis exerts multidimensional effects on embryo implantation, placental development, and uterine contractile function. In early pregnancy, adenomyosis may impair endometrial receptivity and alter the local immune microenvironment, thereby significantly increasing the risk of pregnancy loss. During the second and third trimesters, uterine structural abnormalities and sustained inflammatory activation contribute to higher rates of preterm birth, placental abnormalities and hypertensive disorders of pregnancy, particularly in women with diffuse adenomyosis. During labor and the postpartum period, impaired myometrial contractility and placental complications further increase the risks of postpartum hemorrhage and adverse neonatal outcomes. This review systematically summarizes the associations between adenomyosis and adverse pregnancy outcomes and highlights the need to recognize adenomyosis as a high-risk pregnancy condition, which requires stratified risk assessment systems, dynamic monitoring and individualized management to improve maternal and neonatal outcomes.

[1]
中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第3版)[J]. 中华妇产科杂志202156(12):812-824.
[2]
Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition[J]. J Minim Invasive Gynecol201623(2):164-185.
[3]
Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach[J]. Hum Reprod Update202026(3):392-411.
[4]
Komatsu H, Taniguchi F, Harada T. Impact of adenomyosis on perinatal outcomes: a large cohort study (JSOG database)[J]. BMC Pregnancy Childbirth202323(1):579.
[5]
Rees CO, van Vliet H, Siebers A, et al. The ADENO study: adenomyosis and its effect on neonatal and obstetric outcomes: a retrospective population-based study[J]. Am J Obstet Gynecol2023229(1):49.e1-49.e12.
[6]
Tellum T, Naftalin J, Chapron C, et al. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study[J]. Hum Reprod202237(9):2012-2031.
[7]
Vercellini P, Viganò P, Bandini V, et al. Association of endometriosis and adenomyosis with pregnancy and infertility[J]. Fertil Steril2023119(5):727-740.
[8]
Guo S. Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology[J]. Reproduction2022164(5):R101-121.
[9]
Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy[J]. Nat Med201218(12):1754-1767.
[10]
Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update[J]. Fertil Steril201298(3):572-579.
[11]
Harmsen M J, Van den Bosch T, de Leeuw R A, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure[J]. Ultrasound Obstet Gynecol202260(1):118-131.
[12]
Van den Bosch T, de Bruijn AM, de Leeuw RA, et al. Sonographic classification and reporting system for diagnosing adenomyosis[J]. Ultrasound Obstet Gynecol201953(5):576-582.
[13]
Bulun SE, Yildiz S, Adli M, et al. Adenomyosis pathogenesis: insights from next-generation sequencing[J]. Hum Reprod Update202127(6):1086-1097.
[14]
Bourdon M, Santulli P, Jeljeli M, et al. Immunological changes associated with adenomyosis: a systematic review[J]. Hum Reprod Update202127(1):108-129.
[15]
Shi J, Xu Q, Yu S, et al. Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy[J]. Semin Immunopathol202547(1):16.
[16]
Zheng H, Liu M, Su Q, et al. Impaired fertility and perinatal outcomes in adenomyosis: insights from a novel murine model and uterine gene profile alterations during implantations[J]. Am J Obstet Gynecol2025233(3):180.e1-180.e18.
[17]
Mandelbaum RS, Melville SJF, Violette CJ, et al. The association between uterine adenomyosis and adverse obstetric outcomes: a propensity score-matched analysis[J]. Acta Obstet Gynecol Scand2023102(7):833-842.
[18]
Stanekova V, Woodman RJ, Tremellen K. The rate of euploid miscarriage is increased in the setting of adenomyosis[J]. Hum Reprod Open20182018(3):hoy011.
[19]
Boje AD, Egerup P, Westergaard D, et al. Endometriosis is associated with pregnancy loss: a nationwide historical cohort study[J]. Fertil Steril2023119(5):826-835.
[20]
Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis[J]. Reprod Biomed Online202142(1):185-206.
[21]
Sharma S, Bathwal S, Agarwal N, et al. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients[J]. Reprod Biomed Online201938(1):13-21.
[22]
Han B, Liang T, Zhang W, et al. The effect of adenomyosis types on clinical outcomes of IVF embryo transfer after ultra-long GnRH agonist protocol[J]. Reprod Biomed Online202346(2):346-351.
[23]
Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis[J]. Hum Reprod Update201925(5):592-632.
[24]
倪天翔,颜军昊. 反复胚胎种植失败的原因和处理[J/CD]. 中华产科急救电子杂志20198(3):155-160.
[25]
Cozzolino M, Tartaglia S, Pellegrini L, et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis[J]. Reprod Sci202229(11):3177-3193.
[26]
Jiang L, Han Y, Song Z, et al. Pregnancy outcomes after uterus-sparing operative treatment for adenomyosis: a systematic review and meta-analysis[J]. J Minim Invasive Gynecol202330(7):543-554.
[27]
Guan X, Liu D, Zhou H, et al. Association between pre-pregnancy uterine volume and preterm birth in women with adenomyosis: a retrospective cohort study[J]. BMC Pregnancy Childbirth202525(1):718.
[28]
Yamaguchi A, Kyozuka H, Fujimori K, et al. Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: a cohort study of the Japan Environment and Children′s Study[J]. Acta Obstet Gynecol Scand201998(3):359-364.
[29]
Ni X, Su X, Shi Y, et al. Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study[J]. Ultrasound Obstet Gynecol202464(5):678-686.
[30]
Busnelli A, Simone ND, Somigliana E, et al. Untangling the independent effect of endometriosis, adenomyosis, and ART-related factors on maternal, placental, fetal, and neonatal adverse outcomes: results from a systematic review and meta-analysis[J]. Hum Reprod Update202430(6):751-788.
[31]
Liu L, Zhang K, Gao X, et al. Clinical features and perinatal outcomes in women with adenomyosis[J]. Eur J Obstet Gynecol Reprod Biol2025313:114631.
[32]
Wang Y, Hu Y, Jiang P, et al. Establishment and validation of a nomogram model for predicting adverse pregnancy outcomes of pregnant women with adenomyosis[J]. Arch Gynecol Obstet2024309(6):2575-2584.
[33]
Hashimoto A, Iriyama T, Sayama S, et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition[J]. J Matern Fetal Neonatal Med201831(3):364-369.
[34]
de Rozario T, Jochum F, Schwaab T, et al. Adenomyosis and obstetric complications: a retrospective case-control study[J]. Eur J Obstet Gynecol Reprod Biol2024292:120-124.
[35]
Hashimoto A, Iriyama T, Sayama S, et al. Differences in the incidence of obstetric complications depending on the extent and location of adenomyosis lesions[J]. J Matern Fetal Neonatal Med202336(2):2226789.
[36]
石慧峰,尹韶华,吴天晨,等. 中国助产机构严重产后出血发生现状和防治能力[J]. 实用妇产科杂志202440(3):179-185.
[37]
付以琳,丁文成. 严重产后出血容量复苏[J/OL]. 中华产科急救电子杂志202514(2):75-79.
[38]
Sayama S, Iriyama T, Takeiri Y, et al. Clinical characteristics and outcomes of women with adenomyosis pain during pregnancy: a retrospective study[J]. J Perinat Med202452(2):186-191.
[1] 康林立, 陈璐, 张天歌, 刘勤, 汪龙霞. 妊娠期卵巢子宫内膜异位囊肿蜕膜化的临床及超声影像学特征[J/OL]. 中华医学超声杂志(电子版), 2025, 22(08): 733-739.
[2] 汪浪, 何怡华, 李征毅, 刘翠云, 颉剑锋, 陈健. 母胎超声参数对复发性流产孕妇不良妊娠结局的预测价值[J/OL]. 中华医学超声杂志(电子版), 2025, 22(06): 556-563.
[3] 刘琪, 顾宁, 杨玲, 周燕, 芮燕京, 戴毅敏. 妊娠合并恶性肿瘤的临床特征及母儿结局[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 634-642.
[4] 张雅琪, 熊超, 邱琳, 杨蓉. 妊娠期糖尿病孕妇分娩小于胎龄儿的早期生长发育模式[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 643-649.
[5] 何雯艳, 王悠炯. 手术治疗剖宫产术分娩后难治性产后出血患者疗效的Meta分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 697-706.
[6] 魏艺, 李欣, 凌秀凤, 赵纯. 改良自然周期和来曲唑诱导排卵周期中不同黄体支持方案对高龄及非高龄女性妊娠结局的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(05): 568-579.
[7] 范舒舒, 李玉凤, 林莉, 龙梅, 汪成, 何金娜. 血清25-羟维生素D水平对体外受精-胚胎移植助孕患者妊娠结局的影响及其与外周血和卵泡液淋巴细胞亚群相关性研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(05): 580-589.
[8] 阮希伦, 单臻, 范远键, 林颖, 王深明, 龙健婷, 徐向东. 一项妊娠相关性乳腺癌病理学特征、治疗方案及预后信息的回顾性研究[J/OL]. 中华普通外科学文献(电子版), 2025, 19(05): 340-344.
[9] 赖燕婷, 黄茂宏, 洪平阳, 曾惠清, 杜艳萍, 张孝斌. miR-766-3p/PNCK/mTOR通路在气道上皮细胞机械损伤中的作用研究[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 15-21.
[10] 解加智, 朱博驰, 逄雯珺, 满玉红, 毛西京. 妊娠期自发性脊髓硬膜下出血一例报道[J/OL]. 中华脑科疾病与康复杂志(电子版), 2025, 15(04): 251-253.
[11] 楚光华, 胡春艳, 邓齐. 腹腔镜下不同输卵管妊娠保守性手术治疗的临床效果及生育预后分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(10): 767-771.
[12] 陈艳红, 吴惠婷. 妊娠合并子宫肌瘤并发产后出血[J/OL]. 中华产科急救电子杂志, 2026, 15(01): 6-10.
[13] 龙晟佳, 魏军. 妊娠合并子宫肌瘤与流产[J/OL]. 中华产科急救电子杂志, 2026, 15(01): 11-15.
[14] 赖慧娜, 罗艳敏. 妊娠期子宫肌瘤红色变性的诊疗策略[J/OL]. 中华产科急救电子杂志, 2026, 15(01): 16-20.
[15] 范辉健, 刘娟. 妊娠期子宫肌瘤肉瘤样变性的诊治[J/OL]. 中华产科急救电子杂志, 2026, 15(01): 21-27.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?